Showing results (181-190 of 255) with videos related to
Sort By:
Pageof 26
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 1, 1993
Bed nets for the prevention of malaria and anaemia in pregnancyG Dolan, F O ter Kuile, V Jacoutot, et al.BMJ (Clinical Research Ed.)|March 2, 2002
Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trialG T Lewith, A D Watkins, M E Hyland, et al.JAMA|June 14, 1985
Early clinical signs identify low-risk patients with acute upper gastrointestinal hemorrhageD R Bordley, A I Mushlin, J G Dolan, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1994
Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malariaC Luxemburger, F O ter Kuile, F Nosten, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patientsJ Teitel, E Berntorp, G Dolan, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2014
Managing haemophilia for life: 4th Haemophilia Global SummitJ Astermark, G Dolan, T Hilberg, et al.Biorxiv : the Preprint Server for Biology|July 14, 2025
Coordinated regulation of Mdr1- and Cdr1-mediated protection from antifungals by the Mrr1 transcription factor in emerging Candida sppDhanabala-Subhiksha Rajesh-Khanna, Carolina G Piña Páez, Elora G Dolan, et al.Clinical and Experimental Immunology|December 21, 2006
Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complexK S Brown, M J Keogh, N Tagiuri, et al.Journal of Viral Hepatitis|July 19, 2008
Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populationsL J Brant, M E Ramsay, M A Balogun, et al.Journal of Viral Hepatitis|January 21, 2014
The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapyM Backx, A Lewszuk, J R White, et al.Pageof 26